-
Document de presse | 2017.07.10
AIDS research at the Institut Pasteur
AIDS research at the Institut Pasteur Today, 34 years after Institut Pasteur scientists discovered HIV-1 – a breakthrough that was awarded the Nobel Prize in Medicine in 2008 – AIDS remains a major public health problem, affecting the poorest countries and people in particular: 37 million people live with HIV/AIDS in the world, half of whom do not have access to treatment, and there are...
-
Document de presse | 2017.07.17
Malaria : a genetic marker helps identify super-spreading mosquitoes
Malaria super-spreading mosquitoes can now be identified more easily. Researchers from the Institut Pasteur, CNRS and IRD, in collaboration with scientific teams from four African countries and the United States, have identified a genetic marker that helps detect malaria-susceptible mosquitoes which are more likely to be infected with Plasmodium parasites in the wild, thereby having greater...
-
Document de presse | 2017.07.13
Phage therapy: synergy between bacteriophages and the immune system is essential
Two teams from the Institut Pasteur, in partnership with researchers from Inserm and the Georgia Institute of Technology in the U.S., have demonstrated that in order to ensure the efficacy of phage therapy applied in vivo during bacterial infection, bacteriophages rely on the host's immune response. This synergy is largely based on the crucial action of neutrophil immune cells. The discovery...
-
News | 2017.07.06
Why vaccines are essential
Health professionals are rallying around in support of the French government's plan to make 11 vaccines compulsory for children. Prof. Philippe Sansonetti, a microbiologist and infectious disease specialist at the Institut Pasteur, signed the petition launched by the French Society of Pediatricians, together with more than 1,600 colleagues* and infancy specialists. He reminds us that vaccines are...
-
News | 2017.07.19
Pertussis : progress but lack of surveillance
Whooping cough is a highly contagious respiratory disease caused by the bacterium Bordetella pertussis, and which can be serious, or even fatal, for infants. Using a mathematical model, scientists from Honk Kong University and WHO have just published new estimates of the global weight of the disease. These new estimates indicate that the number of pertussis cases among children under 5 years of...
-
Report | 2017.07.24
AIDS: progress and fresh hope
Having claimed the lives of close to 40 million people (source: OMS 2017) since HIV was discovered in 1983, AIDS is indeed a global health catastrophe. Significant progress has nevertheless been made over the last few years, particularly in developed countries, with longer life expectancy for patients on triple therapy. But this treatment does not eliminate the virus and must be taken for life....
-
Document de presse | 2017.07.26
A protective extracellular matrix underpins HIV infectivity
Human immunodeficiency virus (HIV) induces infected lymphocytes to synthesize an extracellular mesh that contains viral particles, and protects them against the immune system and antiretroviral drugs. This is the conclusion of an ANRS-supported study conducted Maria-Isabel Thoulouze at the Virology department of the Institut (Institut Pasteur/CNRS, UMR 3569 Paris) and her colleagues at Inserm and...
-
Document de presse | 2017.07.13
Hereditary hearing loss: the ear and auditory brain are both affected
Scientists from the Institut Pasteur, Inserm, the Collège de France and Pierre & Marie Curie University have recently demonstrated that mutations in three genes responsible for Usher syndrome – a hereditary condition that affects both hearing and sight – influence not only the workings of the ear, specifically the function of sensory cells in the cochlea, but also the development of the...
-
Document de presse | 2017.07.20
Gene therapy: first results in children with Sanfilippo B syndrome
On July 13, 2017, the journal Lancet Neurology published the results of a gene therapy trial conducted in four children with Sanfilippo type B syndrome (also known as MPS IIIB). This trial is the achievement of a two-decade partnership with financial support of AFM-Téléthon and the cooperation of the charity "Vaincre les Maladies Lysosomales" (VML). After monitoring of the treated children for 30...
-
Article | 2017.08.07
Travel Medicine
The medical and paramedical teams in the International Vaccination Center specialize in preventing diseases that affect travelers. They provide information and vaccinations for anyone planning to travel abroad.
